ORCL Stock Week Ahead: Levels and Scenarios for November 16–20
ORCL stock week ahead for November 16–20: last close 125.35 USD, weekly change 7.97%, support 115.16, resistance 144.54.
By matthew jonathan
November 14, 20266 min read
Logo Oracle — JournalArta illustration
Oracle heads into the week of November 16–20 at 125.35 USD, below its 20-day average and well under the year's high, after a rebound that stalled on Friday. For global investors who track U.S. software and AI-linked stocks, the question is whether the bounce has legs or is only a pause inside a larger downtrend.
Last Week in Review
ORCL closed the five sessions from November 9 to November 13 at 125.35 USD, up 7.97% from the 116.10 close of November 6. The week opened at 117.03. The low of 114.91 came in the first session on November 9, and the high of 130.77 came on November 11. That 13.80% range was wide, and the stock finished at 66% of it.
Two sessions rose and three fell. The standout was November 11, when the stock jumped 8.82%. The weakest was November 10, down 1.51%. Friday gave back 1.38% from the previous close of 127.11.
Participation was thin. Average daily volume was 27,011,400 shares, only 0.62 times the 43,563,895 average of the 20 sessions before the week. Friday's 22,547,400 shares were about half the 20-day norm. A rally on light volume is less convincing than one with heavy buying behind it.
Advertisement
Technical Map for the Week Ahead
The 20-day moving average (SMA20) sits at 126.60, and price is just below it. The 50-day average (SMA50) is at 136.67. The slope of the SMA20 is -2.13% over five days, which describes the average's direction, not the stock's price change. Trend is classed as a downtrend, and no new moving-average crossover has formed.
3-month price action chart of ORCL: price, SMA20/50, Bollinger, support & resistance.
On the chart, the 20-day range runs from support at 115.16 to resistance at 144.54, and price sits about 35% of the way up. The three-month range is wider, from a low of 109.21 to a high of 170.70.
Momentum is mixed. The 14-day RSI is 47.0, in neutral territory, and the Stochastic reads 41.1 (%K) and 45.2 (%D). The MACD is -3.734 against a signal line of -4.292. Its histogram has just turned positive at 0.558, which is the only bullish technical signal in the data. Two bearish signals stand against it: the bounce into the SMA20 inside a downtrend, and a falling on-balance volume (OBV) line, which suggests selling pressure is still present.
Momentum chart of ORCL: RSI(14), MACD, Stochastic.
Advertisement
Bollinger Bands (20 days, 2 standard deviations) run from 112.53 at the bottom to 140.66 at the top, with the middle at 126.60. %B is 46%, and the band width of 22.2% is widening, a sign of high volatility. The 14-day ATR, a measure of average daily swing, is 9.46, or 7.5% of the price.
Bullish scenario: if ORCL closes above 20-day resistance at 144.54, it would clear the upper Bollinger Band at 140.66 and the SMA50 at 136.67 on the way, and the downtrend would be in doubt. Bearish scenario: if it slips below 20-day support at 115.16, the week's low of 114.91 would be tested and the 3-month low of 109.21 would come into view.
Fundamentals and Catalysts
Oracle reported quarterly revenue of $19.35 billion for the quarter ended August 31, up 29.6% from $14.93 billion a year earlier, according to its Form 10-Q filed on September 11. In the same filing, net income rose to $4.76 billion from $2.93 billion, and diluted earnings per share were $1.56.
On November 4, the company filed a Form 8-K with the U.S. Securities and Exchange Commission reporting other material events. The research gives no further detail on what it covered.
On November 10, Oracle held a groundbreaking for its future global headquarters on the new East Bank campus in Nashville, Tennessee. The company said the campus will support growth in cloud, AI and healthcare. A technical analysis column dated November 12 noted that the shares have fallen more than 50% at their extremes since the high of June. That context helps explain why a one-week gain of nearly 8% still leaves the stock far from its peak.
Advertisement
Macro, Political and Global Factors
The research available for this report contains no verified macro, policy or global items tied to the week of November 16–20. No economic releases, central bank decisions or regulatory actions are cited here, because none were supplied. The week's move should therefore be read mainly through price and company-specific events.
Risks and What Would Invalidate the Scenario
The bullish case fails if a push toward the upper band is rejected at 140.66 or at the SMA50 of 136.67. In that case the rebound looks like a bounce within a downtrend, which is what one of the two bearish signals describes. Thin volume is a second weakness, since moves on 0.5 times normal turnover can reverse quickly.
The bearish case fails if price holds above 115.16 and recovers the SMA20 at 126.60, with the MACD histogram staying positive. The wide ATR of 9.46 means that daily swings of this size can invalidate either view quickly. The research does not say whether the November 4 filing matters for the stock, so that remains an unknown.
Advertisement
Technical Verdict for the Week: HOLD (wait & see)
The JournalArta research score for ORCL is -58 on a scale from -100 to +100. A buy-side call needs +60 or above and a sell-side call needs -60 or below, so the reading lands in neutral territory, and the call is HOLD (wait & see). Trend and momentum have not lined up yet.
The strongest reasons:
- Price is below both the SMA20 (126.60) and the SMA50 (136.67), and the 20-day average is below the 50-day, which keeps the downtrend intact.
- The MACD histogram has just turned positive at 0.558 and the RSI is a neutral 47.0, so selling momentum has eased without a clear reversal.
- OBV is falling and volume is 0.5 times its 20-day average, so the recent bounce lacks conviction.
The levels below are conditional scenarios from the reference levels, not a forecast:
- Upside scenario, entry range: a close above 20-day resistance at 144.54
- Upside target: 170.70, the 3-month high
- Upside stop loss: 139.53, the price plus 1.5 times ATR
- Downside scenario, entry range: a break below 20-day support at 115.16
- Downside target: 109.21, the 3-month low
- Downside stop loss: 126.60, the SMA20
The verdict is invalidated if price breaks above 144.54 or falls below 115.16, because either move would settle the standoff.
This is technical analysis, not an investment recommendation. The next scheduled event is Oracle's annual meeting of stockholders on Wednesday, November 18, at 9:00 a.m. Central Time. In plain terms, the chart is undecided, so the technical case is to wait for a clear break in either direction.
Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.
